Chimeric Cis-Regulatory Elements for Tissue-Specific Transgene Expression
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing plant transformation technologies struggle to achieve optimal expression levels of multiple transgenes in specific plant tissues, leading to inefficiencies in developing transgenic crops with desired traits.
Innovation Solution
The use of engineered cis-acting regulatory elements, such as promoters, 5′UTRs, and introns, to create chimeric sequences that enhance the expression of coding sequences in transgenic plants, allowing for higher levels of expression in targeted tissues or organs.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional plant transformation technologies are used, then transgenes can be introduced into plants, but optimal expression levels of multiple transgenes in specific plant tissues cannot be achieved
Solution Approach 1:
The regulatory region is divided into multiple modular cis-acting elements (enhancers, promoters, UTRs, introns) that can be independently selected and combined. Each element contributes a specific functional module, allowing researchers to assemble customized regulatory sequences tailored to achieve optimal expression levels in specific plant tissues or organs.
Solution Approach 2:
Specific cis-acting elements are selected and combined based on their known functions and tissue-specificity characteristics. For example, tissue-specific promoters or enhancers are chosen to drive expression in particular plant organs (roots, leaves, fruits), while other elements optimize overall expression efficiency, creating a regulatory sequence with differentiated functional zones.
2Adaptability or versatility
If multiple transgenes are stacked at a single genomic locus, then transgenic plants with multiple desirable traits can be produced, but novel gene regulatory elements are needed to highly express all transgenes
Solution Approach 1:
The chimeric regulatory sequence is designed as a universal platform that can control the expression of multiple different transgenes stacked at a single locus. By incorporating multiple functional cis-acting elements with complementary roles (constitutive promoters for baseline expression, tissue-specific enhancers for localized optimization, UTRs for translational efficiency), the same regulatory architecture can drive high-level expression of diverse transgenes conferring different traits.
3Adaptability or versatility
If transgenes are expressed in specific plant tissues or organs, then desired traits can be achieved in targeted locations, but novel regulatory elements are required to drive appropriate expression patterns
Solution Approach 1:
The regulatory sequence is engineered with specific cis-acting elements that confer tissue-specificity. For example, promoters or enhancers derived from genes naturally expressed in particular plant organs (such as root-specific, leaf-specific, or fruit-specific regulatory sequences) are incorporated to drive transgene expression predominantly in those target tissues, while maintaining high expression efficiency through additional optimization elements.
Data Source
AI summary
Cis-acting regulatory elements were identified and engineered as a modulating element within a regulatory element (for example, a promoter, 5′UTR, intron or 3′UTR). Next, the chimeric cis-acting regulatory element and promoter were assayed to determine if the cis-acting regulatory elements could enhance the expression of a downstream coding sequence operably linked to the chimeric cis-acting regulatory element and promoter. Disclosed are novel cis-acting regulatory elements that were identified to enhance the expression of a downstream coding sequence.